AIG
VERV

American International Group’s Verve Therapeutics VERV Stock Holding History

American International Group’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32,468
Closed -$431K – 2627
2024
Q1 		$431K Buy
32,468
+6,517
+25% +$86.4K ﹤0.01% 1737
2023
Q4 		$362K Buy
25,951
+633
+3% +$7.85K ﹤0.01% 1844
2023
Q3 		$336K Buy
25,318
+900
+4% +$14.5K ﹤0.01% 1829
2023
Q2 		$458K Buy
24,418
+1,850
+8% +$30.8K ﹤0.01% 1695
2023
Q1 		$325K Buy
22,568
+449
+2% +$8.79K ﹤0.01% 1839
2022
Q4 		$428K Buy
22,119
+518
+2% +$13.7K ﹤0.01% 1685
2022
Q3 		$742K Buy
21,601
+4,313
+25% +$138K 0.01% 1346
2022
Q2 		$264K Sell
17,288
-807
-4% -$12.5K ﹤0.01% 2000
2022
Q1 		$413K Buy
18,095
+9,698
+115% +$277K ﹤0.01% 1829
2021
Q4 		$310K Sell
8,397
-251
-3% -$10.5K ﹤0.01% 2096
2021
Q3 		$406K Buy
+8,648
New +$509K ﹤0.01% 1996

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

American International Group's VERV Position: Q2 2024 in Review

American International Group sold out of Verve Therapeutics (VERV) in Q2 2024, closing a stake of 32,468 shares — an estimated $431K sold.

American International Group first reported a position in VERV in Q3 2021 and held it in 11 quarters. The position peaked at $742K in Q3 2022. 166 funds tracked by Wall St. Rank hold VERV as of Q2 2024.

  • American International Group reported no remaining Verve Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 32,468 Verve Therapeutics shares in Q2 2024, an estimated $431K.
  • American International Group first reported a position in Verve Therapeutics in Q3 2021 and held it in 11 quarters.
  • American International Group's Verve Therapeutics position peaked at $742K in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Verve Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.